[{"orgOrder":0,"company":"Wellbeam Consumer Health","sponsor":"Carlin Consumer Health","pharmaFlowCategory":"D","therapeuticArea":"Musculoskeletal","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2024","type":"Acquisition","leadProduct":"Arnica Montana","moa":"||Undisclosed","graph1":"Musculoskeletal","graph2":"Approved FDF","graph3":"Wellbeam Consumer Health","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Cream","sponsorNew":"Wellbeam Consumer Health \/ Carlin Consumer Health","highestDevelopmentStatusID":"15","companyTruncated":"Wellbeam Consumer Health \/ Carlin Consumer Health"},{"orgOrder":0,"company":"Center for Clinical and Cosmetic Research","sponsor":"Ferndale Laboratories, Inc.","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"","productType":"Plant Extract\/Herbal","year":"2013","type":"Inapplicable","leadProduct":"Arnica Montana","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Phase IV","graph3":"Center for Clinical and Cosmetic Research","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Center for Clinical and Cosmetic Research \/ Ferndale Laboratories, Inc.","highestDevelopmentStatusID":"11","companyTruncated":"Center for Clinical and Cosmetic Research \/ Ferndale Laboratories, Inc."}]

Find Clinical Drug Pipeline Developments & Deals for Arnica Montana

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Wellbeam Consumer Health

                          Country arrow
                          AIChE Annual Meeting
                          Not Confirmed

                          Wellbeam Consumer Health

                          Country arrow
                          AIChE Annual Meeting
                          Not Confirmed

                          Details : Through the acquisition, Carlin expands its OTC portfolio with Penetrex, a formulation using natural ingredients like Arnica and Vitamin B6 for joint and muscle pain.

                          Product Name : Penetrex

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Undisclosed

                          April 30, 2024

                          Lead Product(s) : Arnica Montana,Dimethyl Sulfone,Pyridoxine Hydrochloride

                          Therapeutic Area : Musculoskeletal

                          Highest Development Status : Approved FDF

                          Sponsor : Carlin Consumer Health

                          Deal Size : Undisclosed

                          Deal Type : Acquisition

                          blank

                          02

                          Center for Clinical and Cosmetic Research

                          Country arrow
                          AIChE Annual Meeting
                          Not Confirmed

                          Center for Clinical and Cosmetic Research

                          Country arrow
                          AIChE Annual Meeting
                          Not Confirmed

                          Details : Arnica montana is a Other Large Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of undefined medical condition.

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          July 30, 2013

                          Lead Product(s) : Arnica Montana

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Phase IV

                          Sponsor : Ferndale Laboratories, Inc.

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank